Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Mar 31, 2018
- Elisa Long, informed by personal experience, parses data to help those mulling mastectomy and gynecological surgeries
UCLA Anderson Review, Mar 2018 - High Expectations for Immunotherapy in GI Cancers- Immunotherapy may play a growing role in treating gastrointestinal cancers categorized as MSI-high.
A Weintraub, Cure Magazine, Mar 2018 - Despite FDA Approvals of Direct-to-Consumer Tests, People Still Need to See Certified Genetic Counselors
K Powell, Genome Magazine, Mar 29, 2018 - Tumor sequencing superior to other methods of detecting Lynch syndrome in colorectal cancer
Healio News, Mar 29, 2018 - Approvals in 2017: gene therapies and site-agnostic indications.
Blumenthal Gideon M et al. Nature reviews. Clinical oncology 2018 Mar (3) 127-128 - Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer
H Hampel et al, JAMA Oncology, Mar 28, 2018 - Familial communication and cascade testing among relatives of BRCA population screening participants
S Lieberman et al, Genet in Medicine, Mar 29, 2018 - Genetic Testing Helps Guide Treatment in Prostate Cancer
D Bucco, Onclive, Mar 28, 2018 - A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma.
Wang Wei et al. Oncotarget 2016 Sep 7(39) 63526-63536 - BRCA1+ carrier: Why I chose prophylactic surgery
J McCarthy, MD Anderson Blog, Dec 15, 2017
No hay comentarios:
Publicar un comentario